Discontinued Compound definition

Discontinued Compound means either a Selected Compound as to which --------------------- MRE has filed an IND or an Co-Promoted Product as to which MRE has given written notice to DTI of its decision to cease Research and Development or Product Development.
Discontinued Compound shall have the meaning set forth in Section 4.03.
Discontinued Compound shall have the meaning ascribed thereto in Subsection 2.2(b) hereof.

Examples of Discontinued Compound in a sentence

  • MRE shall have the right of first refusal with respect to DTI's proposed grant to any bona fide third party of any right, title or interest of DTI in or to either any such composition, method or process or to any Non-Selected Compound or Discontinued Compound (a "Grant of DTI Rights").

  • At any time after the date of termination or expiration of this Agreement, either party may, upon written notice to the other party, proceed with Pre-Clinical Development and Development of a Discontinued Compound as an Independent Compound or an Independent Product, and such party shall be deemed to be the Independent Party therefor, as provided in Section 3.15.

  • In the event Licensee in its sole and absolute discretion elects to pursue the development of a CT Compound and subsequently discontinues the development of that CT Compound (the "Discontinued Compound"), Licensee shall notify Licensor thereof in writing.

  • If the other party indicates it is interested in participating in and committing resources to conduct Pre-Clinical Development of such Discontinued Compound, such Discontinued Compound shall be designated as a Designated Shared Compound as set forth in Section 3.2(a).

  • If the other party indicates it is interested in participating in and committing resources to conduct Pre-Clinical Development of such Discontinued Compound, such Discontinued Compound shall be designated as a Designated Shared Compound as set forth in Section 4A.2(a).

  • If the other party indicates it is not interested in participating in, and committing resources to, conduct Pre-Clinical Development of such Discontinued Compound, the initiating party, upon notice to the other party, may proceed with Pre-Clinical Development and Development of such Discontinued Compound as an Independent Compound or an Independent Product and the initiating party shall be deemed to be the Independent Party therefor, as provided in Section 4A.15.

  • At any time after [*], either party may, upon written notice to the other party, proceed with Pre-Clinical Development and Development of a Discontinued Compound as an Independent Compound or an Independent Product, and such party shall be deemed to be the Independent Party therefor, as provided in Section 4A.15.

  • Within 120 days of Licensor's receipt of such notification from Licensee, if Licensor desires to re-acquire the rights to the Discontinued Compound, Licensor shall so notify Licensee thereof in writing, setting forth the terms and conditions upon which it is desires to re-acquire such rights, and Licensor and Licensee shall thereafter negotiate such terms and conditions in good faith.

  • If a party provides such notice and the other party indicates it is not interested in participating in, and committing resources to, conduct Pre-Clinical Development of such Discontinued Compound, the initiating party, upon notice to the other party, may proceed with Pre-Clinical Development and Development of such Discontinued Compound as an Independent Compound or an Independent Product and the initiating party shall be deemed to be the Independent Party therefor, as provided in Section 3.15.

  • Immediately upon becoming a Discontinued Compound, the license rights granted by Impetis to Tarus in the applicable Impetis Compound shall revert to Impetis.


More Definitions of Discontinued Compound

Discontinued Compound means any Active Compound, that is (a) not designated by Astellas to be included in a Hit Series within twenty (20) Business Days following the presentation of the results from the HTS Phase for such Active Compound to the JRC, or (b) not designated by Astellas as a Development Compound or a Back-Up Compound by the end of the Development Option Period relating to such Active Compound.

Related to Discontinued Compound

  • Licensed Compound means [***].

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Compounds means a small molecule HMT inhibitor.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Commercialized shall have corresponding meanings.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Terminated Product has the meaning set forth in Section 12.8.1(f).

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.